Danaher Corporation

Stock Chart, Company Information, and Scan Results

$195.22(as of Mar 10, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Danaher Corporation Company Information, Fundamentals, and Technical Indicators

Stock Price$195.22
Ticker SymbolDHR
ExchangeNyse
SectorHealthcare
IndustryDiagnostics & Research
Employees58,000
CountyUSA
Market Cap$140,579.3M
EBIDTA7,835.0M
10-Day Moving Average203.58
P/E Ratio38.41
20-Day Moving Average207.94
Forward P/E Ratio23.15
50-Day Moving Average221.49
Earnings per Share5.03
200-Day Moving Average209.81
Profit Margin17.51%
RSI29.22
Shares Outstanding707.1M
ATR5.29
52-Week High242.80
Volume3,188,935
52-Week Low170.19
Most Recent Support Level193.39
Book Value52,534.0M
Most Recent Resistance Level206.78
P/B Ratio2.64
Upper Keltner219.84
P/S Ratio5.65
Lower Keltner196.04
Debt-to-Equity Ratio219.84
Next Earnings Date04/21/2026
Cash Surplus-2,192.0M
Next Ex-Dividend Date03/27/2026

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands. The Diagnostics segment offers clinical instruments, consumables, software, and services that hospitals, physicians' offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was incorporated in 1969 and is headquartered in Washington, the District Of Columbia.

Danaher Corporation In Our Stock Scanner

As of Mar 11, 2026
example chart graphic
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Oversold Stocks Scan Type: Stock Indicator Scans
As of ---
example chart graphic
Scan Name: Increasing Profit MarginScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.